Senior Enterprise Systems Administrator jobs in United States
cer-icon
Apply on Employer Site
company-logo

CG Oncology · 2 days ago

Senior Enterprise Systems Administrator

CG Oncology is focused on advancing innovative oncology therapies through global clinical trials. The Senior Enterprise Systems Administrator will own and lead clinical, quality, and regulatory enterprise systems, ensuring they are compliant and effective for trial execution.

BiotechnologyHealth CareHealth DiagnosticsOncology

Responsibilities

Own and lead CG Oncology’s clinical, quality, and regulatory enterprise systems (eTMF, CTMS, EDC, IRT, QMS, Veeva QualityDocs & Training, RIM Vault)
Ensure systems are inspection-ready, compliant, and adopted across global Phase I–III trials
Act as the business owner for systems strategy, validation oversight, continuous improvement, and user enablement
Partner with CROs and vendors to ensure data quality, timelines, and budget discipline
Play a visible role in regulatory inspections, audits, and submissions
Help shape how systems scale as CG Oncology grows its pipeline

Qualification

Clinical systems ownershipEnterprise systems managementGCPICHFDA knowledgeFull-cycle drug developmentData quality managementRegulatory complianceStakeholder influenceCross-functional collaborationFast-paced environment adaptability

Required

Have 7+ years of progressive experience supporting enterprise clinical and quality systems in biotech, pharma, or a CRO
Have supported full-cycle drug development (Phase I–III or I–IV), including audits or inspections
Understand GCP, ICH, FDA expectations, and clinical data stewardship deeply
Are comfortable owning systems, influencing cross-functional stakeholders, and working with external partners
Thrive in a small, fast-moving biotech environment where priorities evolve and ownership matters
Prefer roles where impact, accountability, and growth matter more than job titles alone

Preferred

Oncology experience
Small-biotech experience
Prior people leadership

Benefits

ANNUAL PERFORMANCE/MERIT REVIEWS
ANNUAL PERFORMANCE BONUSES
EQUITY
SPECIAL RECOGNITION
FULLY REMOTE WORK ENVIRONMENT
REST AND RECHARGE BENEFITS - Unlimited Flexible Time Off
HOLIDAYS –In 2026 we will observe 14 holidays
RETIREMENT – 401K with 100% company Safe Harbor match up to 4% of base salary
HEALTH (MEDICAL, DENTAL, VISION) – PPO & HDHP – Cigna/Principal
HEALTH SPENDING ACCOUNTS - HSA (with Annual Company Contribution), FSA, FSA-DC
ILLNESS & DISABILITY PROTECTION – Company Paid LTD Coverage + Voluntary Plans
LIFE INSURANCE – Company Paid 1 x base salary + Voluntary Plans
ADDITIONAL EXCLUSIVE BENEFITS – Voluntary Legal, Pet, Plus More

Company

CG Oncology

twittertwittertwitter
company-logo
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.

Funding

Current Stage
Public Company
Total Funding
$555.57M
Key Investors
Kissei PharmaceuticalORI CapitalAlly Bridge Group
2024-12-12Post Ipo Equity· $238M
2024-01-25IPO
2023-08-02Series F· $105M

Leadership Team

A
Amy Steele
VP - Finance, Accounting & Administration
linkedin
Company data provided by crunchbase